Proteomics International Laboratories
Proteomics International Laboratories (ASX:PIQ) is an emerging life science company.
Related news
- Proteomics International Laboratories Ltd grows revenue by 60%
2016-05-20 - Proteomics International Laboratories Ltd expands into key Indian market
2016-04-14 - Proteomics International Laboratories Ltd to utilise disruptive drug technology
2016-03-23 - Proteomics International Laboratories continues partnering discussions
2016-03-08 - Proteomics enhances cash reserves as global marketing drive continues
2015-11-18 - Proteomics eyes Asian markets as medical test gains global exposure
2015-11-04 - Proteomics shares climb on granted U.S. patent for diagnostic test
2015-10-27 - Proteomics lauded for global biotech marketing prowess
2015-10-19 - Proteomics marks traction on a global scale
2015-09-25 - Proteomics has world first predictive test for diabetic kidney disease
2015-06-09 - Proteomics International key patent accepted for kidney diagnostic test
2015-05-21 - Proteomics International wins contract with biopharmaceutical company
2015-04-28 - Proteomics International wins contract with a2 Milk Company
2015-04-23 - Proteomics International targets multi-billion dollar biotech markets
2015-04-15 - Proteomics raising at least $3M to fund protein analysis businesses
2015-02-20 - Proteomics International's Richard Lipscombe speaks with Proactive Investors
2014-12-05 - Proteomics seeks $6M for ASX listing to fund protein analysis businesses
2014-11-24
